CDH2 and neoplasm: In addition, silent corticotroph PitNETs exhibit characteristics of epithelial to mesenchymal transition (i.e., N-cadherin (CDH2) and mesenchymal matrix markers (COL1A1, COL4A1)), pointing to an increased tumor migration potential [62,63].